A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)

Dades bibliogràfiques
Autors principals:	Couillard, S, Laugerud, A, Jabeen, M, Ramakrishnan, S, Melhorn, J, Hinks, TSC, Pavord, ID
Format:	Conference item
Idioma:	English
Publicat:	American Thoracic Society 2021

Ítems similars

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
per: Couillard Castonguay, S, et al.
Publicat: (2022)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
per: Couillard, S, et al.
Publicat: (2021)

To what extent does the prototype ORACLE scale predict treatment benefits? Predicted versus observed impact of anti-inflammatory treatments
per: Couillard, S, et al.
Publicat: (2021)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
per: Howell, I, et al.
Publicat: (2023)

Antibiotics for asthma attacks: masking uncertainty
per: Ramakrishnan, S, et al.
Publicat: (2021)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
per: Imran Howell, et al.
Publicat: (2023-06-01)

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
per: Oliver, ME, et al.
Publicat: (2021)

Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma
per: Couillard, S, et al.
Publicat: (2021)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
per: Lavoie, G, et al.
Publicat: (2024)

Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma
per: Couillard, S, et al.
Publicat: (2022)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
per: Moran, AM, et al.
Publicat: (2020)

The upper and lower airway microbiome in severe asthma
per: Jabeen, M, et al.
Publicat: (2022)

Inflammatory and clinical prognostic factors for asthma attacks: a patient-level meta-analysis of control arms of 22 randomised trials
per: Meulmeester, FL, et al.
Publicat: (2025)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
per: Couillard, S, et al.
Publicat: (2021)

How I do it: workup of severe asthma
per: Couillard, S, et al.
Publicat: (2021)

How have we measured trial outcomes of asthma attack treatment? A systematic review
per: Imran Howell, et al.
Publicat: (2024-02-01)

Biological therapies for asthma
per: Couillard Castonguay, S, et al.
Publicat: (2021)

Headlines for Health! Asthma Attack!
per: Joy C. Jordan, et al.
Publicat: (2007-08-01)

Headlines for Health! Asthma Attack!
per: Joy C. Jordan, et al.
Publicat: (2007-08-01)

Headlines for Health! Asthma Attack!
per: Joy C. Jordan, et al.
Publicat: (2007-08-01)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
per: Hinks, TSC, et al.
Publicat: (2022)

Evaluation of Knowledge Among Pediatricians on Childhood Asthma and Asthma Attack
per: Tarık Kırkgöz, et al.
Publicat: (2021-05-01)

Treatment options in type-2 low asthma
per: Hinks, TSC, et al.
Publicat: (2020)

Ozone Exposure and Asthma Attack in Children
per: Wanting Huang, et al.
Publicat: (2022-04-01)

Persistent hypoxemia after an asthma attack
per: Cristian Deana, et al.
Publicat: (2019-03-01)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
per: Moran, A, et al.
Publicat: (2020)

Asthma in pregnancy: An update
per: Couillard, S, et al.
Publicat: (2020)

Blood eosinophils, fractional exhaled nitric oxide, and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
per: Couillard, S, et al.
Publicat: (2022)

Psychological factors in asthma control and attack risk.
per: Osman, L
Publicat: (2002)

The effect of lead exposure on occurrence of asthma attacks
per: Saeed Samarghandian, et al.
Publicat: (2014-11-01)

Severe Asthma Attack-associated Middle Lobe Syndrome in an Uncontrolled Asthma Patient
per: Muhammed Yusuf Mila, et al.
Publicat: (2023-04-01)

Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
per: Richard Beasley, et al.
Publicat: (2022-04-01)

Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma
per: Jabeen, MF, et al.
Publicat: (2024)

Pneumomediastinum and pneumopericardium in an adolescent with asthma attacks. Case report
per: María Fernanda Ochoa-Ariza, et al.
Publicat: (2020-01-01)

Asthma-like attacks terminated by slow pathway ablation
per: Selcuk Ozturk, et al.
Publicat: (2017-01-01)

Dynamics of inhaled corticosteroid use are associated with asthma attacks
per: Joy Lee, et al.
Publicat: (2021-07-01)

On configurable SCA countermeasures against single trace attacks for the NTT
per: Ravi, Prasanna, et al.
Publicat: (2021)

The effect of short-term particular matter exposure on asthma attacks in asthma children in Fukuoka, Japan
per: Song Han Lee, et al.
Publicat: (2018-01-01)

Assessing the risk of attack in the management of asthma: A review and proposal for revision of the current control-centred paradigm
per: Blakey, J, et al.
Publicat: (2013)

Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm.
per: Blakey, J, et al.
Publicat: (2013)